| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | -0.013 | 0.9 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.0034 | 1 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.0026 | 1 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.0094 | 1 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | 0.0033 | 1 |